Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation

Transplant Proc. 1998 Jun;30(4):1538-40. doi: 10.1016/s0041-1345(98)00348-0.

Authors

D S Bruce¹, E S Woodle, K A Newell, J M Millis, D C Cronin 2nd, G E Loss, H P Grewal, C T Siegel, S Pellar, M A Josephson, J R Thistlethwaite Jr

Affiliation

¹ Department of Surgery, University of Chicago, Illinois 60637, USA.

PMID: 9636625
DOI: 10.1016/s0041-1345(98)00348-0

No abstract available

Publication types

Comparative Study

MeSH terms

Biological Availability
Cyclosporine / therapeutic use*
Drug Therapy, Combination
Graft Rejection / epidemiology
Graft Rejection / prevention & control
Graft Survival
Humans
Immunosuppression Therapy
Immunosuppressive Agents / pharmacokinetics
Immunosuppressive Agents / therapeutic use*
Kidney Transplantation / immunology*
Kidney Transplantation / mortality
Kidney Transplantation / physiology
Mycophenolic Acid / analogs & derivatives*
Mycophenolic Acid / pharmacokinetics
Mycophenolic Acid / therapeutic use
Pancreas Transplantation / immunology*
Pancreas Transplantation / mortality
Pancreas Transplantation / physiology
Recurrence
Retrospective Studies
Survival Rate
Tacrolimus / therapeutic use*

Substances

Immunosuppressive Agents
Cyclosporine
Mycophenolic Acid
Tacrolimus